Jiangsu Hengrui Pharmaceuticals Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ETOPOSIDE USP, with a corresponding US DMF Number 8647.
Remarkably, this DMF maintains an Active status since its submission on July 02, 1990, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 07, 2015, and payment made on April 15, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II